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ABSTRACT 
HIV-1 infected individuals are subject to a chronic immune activation resulting from HIV-1 
replication, microbial translocation, and lymphopenia. Despite the great advance of 
antiretroviral treatment (ART), the immune activation remains associated with poor immune 
reconstitution during HIV-1 infection. The overall aim of this PhD thesis is to contribute to a 
better understanding of the causes and consequences of immune activation, possibly leading to 
the design of improved therapy for HIV-1 infected individuals.  
Premature senescence of T cells, as a consequence of immune activation, is thought to be 
associated with the increased levels of CD28- T cells during HIV-1 infection. In Paper I, the 
phenotype and functional properties of CD28- T cells from HIV-1 individuals naïve to 
treatment, under ART and uninfected controls were assessed. Despite displaying similar 
markers of senescence, and late differentiation, we found that whereas CD28- T cells from 
untreated patients are highly susceptible to both spontaneous and activation-induced 
apoptosis, the same T cell population from ART-treated patients showed an enhanced capacity 
to proliferate upon weak TCR stimulation. Importantly, apoptosis of CD28- T cells from 
untreated patients was correlated with HIV-1 viral load, and their decreased ability to 
proliferate was associated with a reduced IL-2 production. High levels of CD28- T cells during 
HIV-1 infection might result from the chronic immune activation, whereas their sustained 
levels despite ART, is likely to arise from their capacity to proliferate under weak TCR signaling. 
Furthermore, with a capacity to produce IFN-, TNF and perforin, CD28- T cells from HIV-1 
infected individuals might also contribute to the immune activation.  
The mechanisms underlying the loss of memory B cells and the decline of serological memory 
during HIV-1 infection remain elusive. As microbial translocation and the associated immune 
activation have been shown to correlate with T cell depletion, we evaluated, in Paper II, the 
association between the serum levels of soluble CD14, a marker of microbial translocation, with 
the loss of resting memory B cells in HIV-1 infected individuals. Soluble CD14 levels were found 
to correlate with both the decline of resting memory B cells, and their increased expression of 
IL-21R. IL-21R expression on memory B cells was increased during HIV-1 infection, and also 
negatively correlated with the levels of circulating memory B cells. Notably, IL-21R positive 
memory B cells were more prone to apoptosis, measured by higher Annexin V staining and 
lower Bcl-2 expression, as compared to B cells lacking the receptor. Furthermore, TLR 
triggering by microbial products resulted in IL-21R expression on memory B cells in vitro. Our 
results identify a novel role for microbial translocation and the associated immune activation, 
contributing to the loss of memory B cells during HIV-1 infection.  
Lymphopenic conditions are associated with increased IL-7. This cytokine involved in T cell 
homeostasis, is also found to be elevated in HIV-1 infected individuals concomitantly with low 
CD4+ T cell counts; although the regulation of IL-7 production is not fully understood in the 
context of HIV-1 infection. Using human intestinal epithelial (DLD-1) and bone marrow stromal 
(HS-27) cell lines, we investigated in Paper III, the consequence of pro-inflammatory cytokines 
on IL-7 production, measured at the mRNA and the protein levels. Whereas IFN- induced high 
IL-7 production in both cell lines, IL-1 treatment led to the opposite effect. We also analyzed 
the gene expression profiles of HS-27 cells treated with IL-1 and/or IFN- using the whole-
genome microarray Human Gene 1.0 ST. Both cytokines resulted in enhanced expression of 
genes implicated in T cell immunity, particularly important during HIV-1 pathogenesis. Our 
results show that the immune activation can lead to profound change in stromal and epithelial 
cells, which in turn might shape immune responses.  
While IL-7 is known to participate to T cell homeostasis, it has recently been shown that this 
cytokine possibly contribute to B cell defects, leading through IFN-release by T cells, to Fas 
up-regulation and sensitivity to Fas-mediated apoptosis. We further evaluated IL-7 regulation 
of T cell survival in Paper IV, and observed that B cells, co-cultured with IL-7 treated T cells, 
proliferated, displayed a phenotype of differentiated cells and secreted high levels of 
immunoglobulins (Igs). The Ig secretion was demonstrated to be a consequence of CD70          
up-regulation on T cell upon IL-7 treatment.  IL-7 led also to BAFF production by T cells, which 
enhanced B cell survival. In the context of HIV-1 infection, such mechanisms might be 
implicated in the B cell activation and hypergammaglobulinemia observed in patients.  
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